Evidence map›Paper›PMID 25510860›Full record

ArticleBMC complementary and alternative medicine2014

Pleurotus ostreatus opposes mitochondrial dysfunction and oxidative stress in acetaminophen-induced hepato-renal injury.

Yahya M Naguib, Rania M Azmy, Rehab M Samaka, Mohamed F Salem

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Methanolic Extract ofCurrent issues in molecular biology · 2026
    Article
  3. Foods (Basel, Switzerland) · 2026
    Article
  4. Nephroprotective Effect of Methanolic Extract ofInternational journal of molecular sciences · 2026
    Article
  5. Frontiers in pharmacology · 2026
    Article
  6. Protective Effects of Methanolic Extract ofInternational journal of molecular sciences · 2025
    Article
  7. Review
  8. Article
  9. Lead detoxification of edible fungiFrontiers in nutrition · 2023
    Article
  10. Nutrients · 2022
    Article
  11. Hepatoprotective Effect ofFrontiers in pharmacology · 2022
    Article
  12. Hepatoprotective effect ofPharmaceutical biology · 2021
    Article
  13. Article
  14. Nephroprotective Effect ofBiomolecules · 2020
    Article
  15. Article
  16. Protective effects ofFood science and biotechnology · 2018
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yahya M NaguibDepartment of Clinical Physiology, Faculty of Medicine, Menoufia University, Menoufia, Egypt. yahya.naguib@med.menofia.edu.eg.
Rania M Azmy
Rehab M Samaka
Mohamed F Salem
Menoufia University · EGUniversity of Sadat City · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcetaminophen (APAP)-induced toxicity is a predominant cause of acute hepatic and renal failure. In both humans and rodents toxicity begins with a reactive metabolite that binds to proteins. This leads to mitochondrial dysfunction and nuclear DNA fragmentation resulting in necrotic cell death. Pleurotus ostreatus (an edible oyster mushroom) is well recognized as a flavourful food, as well as a medicinal supplement. In the present study, we evaluated the role of Pleurotus ostreatus in the protection against APAP-induced hepato-renal toxicity. We also explored the mechanism by which Pleurotus ostreatus exerts its effects.

methodsNinety adult male Swiss albino mice were divided into three groups (30 mice/group). Mice were offered normal diet (control and APAP groups), or diet supplemented with 10% Pleurotus ostreatus (APAP + Pleurotus ostreatus) for 10 days. Mice were either treated with vehicle (control group, single intra-peritoneal injection.), or APAP (APAP and APAP + Pleurotus ostreatus groups, single intra-peritoneal injection, 500 mg/kg), 24 hours after the last meal.

resultsAPAP increased serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) glutamate dehydrogenase (GDH), creatinine, blood urea nitrogen (BUN), urinary kidney injury molecule-1 (KIM-1), and hepatic and renal malondialdehyde (MDA) content. APAP decreased hepatic and renal glutathione (GSH) content, as well as glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activities. Supplementation with Pleurotus ostreatus significantly reduced APAP-induced elevated levels of ALT, AST, GDH, creatinine, BUN, KIM-1and MDA, while GSH level, and GSH-Px and SOD activities were significantly increased. Our findings were further validated by histopathology; treatment with Pleurotus ostreatus significantly decreased APAP-induced cell necrosis in liver and kidney tissues.

conclusionsWe report here that the antioxidant effect of Pleurotus ostreatus opposes mitochondrial dysfunction and oxidative stress accompanying APAP over-dose, with subsequent clinically beneficial effects on liver and kidney tissues.

Indexed as

PleurotusAcetaminophenAlanine TransaminaseAnimalsAntioxidantsAspartate AminotransferasesBiological ProductsChemical and Drug Induced Liver InjuryDietary SupplementsGlutathioneGlutathione PeroxidaseKidneyKidney DiseasesLiverMaleMalondialdehydeAcetaminophenAlanine TransaminaseAntioxidantsAspartate AminotransferasesBiological ProductsGlutathioneGlutathione PeroxidaseMalondialdehyde

Identifiers

PMID25510860
PMCPMC4301462
OpenAlexW1563506939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.